Biomap, a
biotech startup co-founded by
Baidu’s Robin Li and backed by Hong Kong’s government, said it has surpassed AlphaFold in commercializing
AI models for drug discovery. CEO Wei Liu cited rising pharma adoption as Biomap expands through BioGend Science, a Hong Kong-based venture aiming to bring drugs to clinical trials within two years.